Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
QuintilesIMS
Moodys
Chinese Patent Office
Johnson and Johnson
Cantor Fitzgerald
Mallinckrodt
US Department of Justice
Citi

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 065167

« Back to Dashboard

NDA 065167 describes CYCLOSPORINE, which is a drug marketed by Apotex, Ivax Sub Teva Pharms, Mayne Pharma, Sandoz, Luitpold, West-ward Pharms Int, Abbvie, Apotex Inc, and Wockhardt Bio Ag, and is included in eleven NDAs. It is available from nine suppliers. Additional details are available on the CYCLOSPORINE profile page.

The generic ingredient in CYCLOSPORINE is cyclosporine. There are eighteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the cyclosporine profile page.
Summary for 065167
Tradename:CYCLOSPORINE
Applicant:Apotex Inc
Ingredient:cyclosporine
Patents:0
Therapeutic Class:Immunological Agents
Ophthalmic Agents
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION;ORALStrength100MG/ML
Approval Date:Jan 5, 2005TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Cipla
Harvard Business School
McKinsey
Cerilliant
Cantor Fitzgerald
Fuji
Merck
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.